Global Blood Therapeutics
Signal active
Organization
Contact Information
Overview
GBT is a clinical-stage biopharmaceutical company that focuses on discovering, developing, and delivering innovative treatments that provide hope to underserved patient communities. GBT is developing its product candidate, voxelotor, as an oral, once-daily therapy for sickle cell disease.
It was founded in 2012 and is headquartered in San Francisco, California.
About
Industries
Biotechnology, Medical, Therapeutics, Genetics
Founded
2011
Employees
251-500
Headquarters locations
South San Francisco, California, United States, North America
Social
Profile Resume
Global Blood Therapeutics headquartered in United States, North America, operates in the Biotechnology, Medical, Therapeutics, Genetics sector. The company focuses on Biotechnology and has secured $108.6B in funding across 112 round(s). With a team of 251-500 employees, Global Blood Therapeutics is actively contributing to advancements in Biotechnology. Their latest funding round, Series A - Global Blood Therapeutics, raised $40.7M. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
Funding rounds
7
Investors
1
Lead Investors
0
Total Funding Amount
$969.5M
Details
2
Global Blood Therapeutics has raised a total of $969.5M in funding over 2 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|---|---|---|---|
| 2015 | Early Stage Venture | 48.0M | ||
| 2012 | Early Stage Venture | 40.7M |
Investors
Global Blood Therapeutics is funded by 10 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| Deerfield | - | FUNDING ROUND - Deerfield | 48.0M |
| Kevin Starr | - | FUNDING ROUND - Kevin Starr | 40.7M |
| Global Blood Therapeutics | - | FUNDING ROUND - Global Blood Therapeutics | 40.7M |
| Third Rock Ventures | - | FUNDING ROUND - Third Rock Ventures | 40.7M |
Recent Activity
Funding Round
Dec 15, 2021
Global Blood Therapeutics raised $300000000 on 2021-12-15 in Post-IPO Debt
Funding Round
Jun 26, 2019
Global Blood Therapeutics raised $200000000 on 2019-06-26 in Post-IPO Equity
Funding Round
Aug 01, 2017
Global Blood Therapeutics raised $125000000 on 2017-08-01 in Post-IPO Equity
Funding Round
Feb 21, 2017
Global Blood Therapeutics raised $143800000 on 2017-02-21 in Post-IPO Equity
Funding Round
Jun 20, 2016
Global Blood Therapeutics raised $112000000 on 2016-06-20 in Post-IPO Equity